Mergers & Acquisitions

The healthcare industry sees a lot of consolidation between both vendors and healthcare providers this channel tracks mergers and acquisitions between large healthcare systems, community hospitals, private practices, vendors and private equity investors. Health systems have been growing in size substantially in the past decade with mergers with smaller healthcare systems and hospitals. This is largely due to the need to be more efficient amid lower reimbursements and rising costs by building an economy of scale in a larger health system. On the vendor side, mergers have become a common way to reduce research and development costs by purchasing intellectual rights for new technologies, or to purchased companies with new technologies that already have regulatory market clearance. 

artificial intelligence money finance acquisition

Zevra inks deal worth up to $91M to strengthen rare disease portfolio

Zevra Therapeutics has agreed to acquire Acer Therapeutics, taking over the commercialization of two of the company's key offerings. 

M&A mergers and acquisitions business deal

Centene to offload UK hospital system for $1.2B

The company reached a definitive agreement to sell Circle Health to the largest health system in the Middle East.

Thumbnail

Novo Nordisk close to acquiring French medical device company for $165M

The two companies first started collaborating on diabetes technology in 2021. The acquisition is not yet final, but Novo Nordisk now holds the exclusive negotiation rights.

Medtronic acquires insulin patch manufacturer for $738M

The deal represents a significant step forward for Medtronic's diabetes portfolio.

Kaiser Permanente acquiring Geisinger, launching new nonprofit

The new entity, Risant Health, will continue growing through acquisitions and the connection of like-minded health systems.

Merck to acquire Prometheus Biosciences for $10.8B

The acquisition is one of 2023's biggest healthcare deals so far.

Thumbnail

Sanofi’s $2.9B acquisition of Provention Bio delayed by FTC review

According to Sanofi, it has withdrawn and refiled its premerger notification and report form with the FTC to give the agency more time to review the deal.

Private equity in healthcare: Deals decreased in 2022, but market was still active

"Healthcare private equity has earned a recession-proof reputation," according to one expert. 

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”